European Medicines Agency Human Scientific Committees' Working Party with Patients' and Consumers' Organisations (PCWP) plenary meeting with all eligible organisations

Date: 30/11/2011
Location: London, UK
Day 2: This meeting includes an introduction from the new Executive Director. Some of the general issues for discsussion at the meeting are the implementation of the anti-falsification legislation; additional monitoring of medicines and direct patient reporting; legislation on information to patients; results of survey project on representativeness in Agency stakeholder groups; outcome of the scientific advisory group pilot phase; and process for re-evaluation of eligibility.Registration by invitation only.


How useful was this page?

Add your rating